Axitan Limited, a leading biotech company focused on the development of endolysin enzyme products to replace antibiotics in animal feed, today announces that it has entered into a strategic ...
EXL-01 is under clinical development by Exeliom Biosciences and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated Disease). According to GlobalData, Phase ...